Genes, cancer and the lymphatic system

submitted by: MarkShriver

Current Yale University Graduate Student and Morehouse College alumnus, Dennis Jones discusses some of his research on the BMX gene in a mouse model of cancer progression.

PharmGenEd™ Principles and Concepts of Pharmacogenomics

submitted by: KuoOffice

The presentation is divided into several sections as outlined by the powerpoint slide. In this module we will include the basic concepts of pharmacogenomics, ethical, legal, social issues, and a brief introduction of the PharmGenEd program.

Funny Catheter Recycle Video

submitted by: colonialmed

With help from Trisolt Video Productions. We created a video to help payer sources, caregivers, and Healthcare Profesionals relate to the concept of not recycling Intermttent Catheters. Take a look and let us know what you think. If you would like to learn more about our Service Plus Program. Please call 800-747-0246 or visit www.colonialmed.com

Dietary protein and bone health: a systematic review and meta-analysis.

submitted by: adarling
BACKGROUND: There has been a resurgence of interest in the controversial relation between dietary protein and bone health. OBJECTIVE: This article reports on the first systematic review and meta-analysis of the relation between protein and bone health in healthy human adults. DESIGN: The MEDLINE (January 1966 to September 2007) and EMBASE (1974 to July 2008) databases were electronically searched for all relevant studies of healthy adults; studies of calcium excretion or calcium balance were...
Authors: Al Darling, Dj Millward, Dt Torgerson, Ce Hewitt, Sa Lanham-new

PharmGenEd: Clinical Application of Pharmacogenomics

submitted by: KuoOffice
We will review the use of pharmacogenomic tests in five therapeutic areas. Infectious disease Oncology Anticoagulation Psychiatry Neurology Within each therapeutic area, we will include the following: The gene or allele of interest The functional effect of the gene or allele The prevalence of the relevant alleles in various populations The available genomic tests A summary of the most significant clinical data available to date, regarding Drug dosing and selection Drug efficacy...

Mel Reichman on Pool Shark’s Cues for More Efficient Drug Discovery

submitted by: jcbradley
Mel Reichman, senior investigator and director of the LIMR Chemical Genomics Center at the Lankenau Institute for Medical Research presents at the chemistry department at Drexel University on November 12, 2009. Introduction by Jean-Claude Bradley. Modern drug discovery by high-throughput screening (HTS) begins with testing hundreds of thousands of compounds in biological assays. The confirmed hit rate for typical HTS is less than 0.5%; therefore, 99.5% of the costs of HTS are for...